This site is intended for healthcare professionals only
LoginRegister

Cardiology-CTVS Dialogues

Stem cell therapy linked to lower risk of heart failure after a heart attack: Study

Stem cell therapy linked to lower risk of heart failure after a heart attack: Study

Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related...
View All

Latest News and Guidelines

FDA Expands Indication for Sotatercept-csrk in Pulmonary Arterial Hypertension

FDA Expands Indication for Sotatercept-csrk in Pulmonary Arterial Hypertension

TCT 2025: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years, PARTNER-3 Trial Findings

TCT 2025: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years,...

TCT 2025: OCVC-BIF Trial Compares Drug-Coated Balloon Versus Conventional Balloon for Treatment of Side Branches in Coronary Bifurcation Lesions

TCT 2025: OCVC-BIF Trial Compares Drug-Coated Balloon Versus Conventional Balloon for Treatment of...

USFDA Approves Alembics Dapagliflozin Tablets, Grants 180-Day Exclusivity

Alembic Pharma wins USFDA nod for heart disease drug

New Drug-Eluting Balloon Matches Standard Stents in Safety and Effectiveness: SELUTION4ISR Trial

New Drug-Eluting Balloon Matches Standard Stents in Safety and Effectiveness: SELUTION4ISR Trial

TCT 2025: One-Year ENCIRCLE Trial Outcomes Highlight Reduced Mortality and Heart Failure (HF) Admissions with Transcatheter Mitral Valve Replacement (TMVR) Using SAPIEN M3 System

TCT 2025: One-Year ENCIRCLE Trial Outcomes Highlight Reduced Mortality and Heart Failure (HF)...

View All
X